Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


30.01.2017

1 Am J Psychiatry
1 Biol Psychiatry
1 Br J Psychiatry
1 Clin Neuropharmacol
2 Compr Psychiatry
1 J Clin Psychiatry
3 Mol Psychiatry
3 PLoS One
6 Psychiatry Res
1 Psychol Med
12 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Psychiatry

  1. RAJKUMAR AP, Horsdal HT, Wimberley T, Cohen D, et al
    Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
    Am J Psychiatry. 2017 Jan 20:appiajp201616040442.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  2. BUGARSKI-KIROLA D, Blaettler T, Arango C, Fleischhacker WW, et al
    Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
    Biol Psychiatry. 2016 Dec 15. pii: S0006-3223(16)33109.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  3. ZHUO C, Zhu J, Qin W, Qu H, et al
    Cerebral blood flow alterations specific to auditory verbal hallucinations in schizophrenia.
    Br J Psychiatry. 2017 Jan 19. pii: bjp.bp.115.174961.
    PubMed     Text format     Abstract available


    Clin Neuropharmacol

  4. RONCERO C, Ros-Cucurull E, Grau-Lopez L, Fadeuilhe C, et al
    Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series.
    Clin Neuropharmacol. 2016;39:206-9.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  5. DE CAMPOS-CARLI SM, Miranda AS, Dias IC, de Oliveira A, et al
    Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia.
    Compr Psychiatry. 2017;74:96-101.
    PubMed     Text format     Abstract available

  6. JEYAGURUNATHAN A, Vaingankar JA, Abdin E, Sambasivam R, et al
    Gender differences in positive mental health among individuals with schizophrenia.
    Compr Psychiatry. 2017;74:88-95.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  7. HAUSER M, Zhang JP, Sheridan EM, Burdick KE, et al
    Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    J Clin Psychiatry. 2017;78:e28-e40.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  8. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available

  9. ROALF DR, Nanga RP, Rupert PE, Hariharan H, et al
    Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available

  10. VAUCHER J, Keating BJ, Lasserre AM, Gan W, et al
    Cannabis use and risk of schizophrenia: a Mendelian randomization study.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    PLoS One

  11. KILIAN S, Burns JK, Seedat S, Asmal L, et al
    Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia.
    PLoS One. 2017;12:e0170178.
    PubMed     Text format     Abstract available

  12. YEE JY, Nurjono M, Teo SR, Lee TS, et al
    GAD1 Gene Expression in Blood of Patients with First-Episode Psychosis.
    PLoS One. 2017;12:e0170805.
    PubMed     Text format     Abstract available

  13. PANG L, Kennedy D, Wei Q, Lv L, et al
    Decreased Functional Connectivity of Insular Cortex in Drug Naive First Episode Schizophrenia: In Relation to Symptom Severity.
    PLoS One. 2017;12:e0167242.
    PubMed     Text format     Abstract available


    Psychiatry Res

  14. WEISS EM, Singewald E, Baldus C, Hofer E, et al
    Differences in psychological and somatic symptom cluster score profiles between subjects with Idiopathic environmental intolerance, major depression and schizophrenia.
    Psychiatry Res. 2017;249:187-194.
    PubMed     Text format     Abstract available

  15. MERRILL AM, Karcher NR, Cicero DC, Becker TM, et al
    Evidence that communication impairment in schizophrenia is associated with generalized poor task performance.
    Psychiatry Res. 2017;249:172-179.
    PubMed     Text format     Abstract available

  16. IASEVOLI F, Fagiolini A, Formato MV, Prinzivalli E, et al
    Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients.
    Psychiatry Res. 2017;249:159-166.
    PubMed     Text format     Abstract available

  17. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse.
    Psychiatry Res. 2017;249:200-205.
    PubMed     Text format     Abstract available

  18. JIMENEZ AM, Lee J, Green MF, Wynn JK, et al
    Functional connectivity when detecting rare visual targets in schizophrenia.
    Psychiatry Res. 2017;261:35-43.
    PubMed     Text format     Abstract available

  19. POE SL, Brucato G, Bruno N, Arndt LY, et al
    Sleep disturbances in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2016;249:240-243.
    PubMed     Text format     Abstract available


    Psychol Med

  20. STONE J, Koychev I, Reilly T, McGuire P, et al
    Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2017 Jan 23:1. doi: 10.1017/S0033291716003470.
    PubMed     Text format    


    Schizophr Res

  21. KIM SW, Polari A, Melville F, Moller B, et al
    Are current labeling terms suitable for people who are at risk of psychosis?
    Schizophr Res. 2017 Jan 20. pii: S0920-9964(17)30040.
    PubMed     Text format     Abstract available

  22. SMESNY S, Milleit B, Schaefer MR, Hesse J, et al
    Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Schizophr Res. 2017 Jan 23. pii: S0920-9964(17)30039.
    PubMed     Text format     Abstract available

  23. VINCENT PD, Demers MF, Doyon-Kemp V, Duchesneau J, et al
    One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30026.
    PubMed     Text format     Abstract available

  24. WU CHOU AI, Wang YC, Lin CL, Kao CH, et al
    Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30028.
    PubMed     Text format     Abstract available

  25. BAI Z, Wang G, Cai S, Ding X, et al
    Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30001.
    PubMed     Text format     Abstract available

  26. KU HL, Wang JK, Lee HC, Lane TJ, et al
    Cerebral blood flow autoregulation is impaired in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30024.
    PubMed     Text format     Abstract available

  27. D'ADDARIO C, Micale V, Di Bartolomeo M, Stark T, et al
    A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30031.
    PubMed     Text format     Abstract available

  28. LIN CH, Wang FC, Lin SC, Huang YH, et al
    A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30004.
    PubMed     Text format     Abstract available

  29. ANDRIANARISOA M, Boyer L, Godin O, Brunel L, et al
    Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(16)30596.
    PubMed     Text format     Abstract available

  30. FIKSINSKI AM, Breetvelt EJ, Duijff SN, Bassett AS, et al
    Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30044.
    PubMed     Text format     Abstract available

  31. PINTO JV, Passos IC, Gomes F, Reckziegel R, et al
    Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach.
    Schizophr Res. 2017 Jan 16. pii: S0920-9964(17)30023.
    PubMed     Text format    

  32. PARK CH, Lee S, Kim T, Won WY, et al
    Different alterations in brain functional networks according to direct and indirect topological connections in patients with schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30038.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: